Animal Welfare & Antibiotics Policy
With experience in developing Animal Welfare & Antibiotics Policies for Fortune 500 companies and with Dr. Temple Grandin as our advisor, we write, review and fine-tune policies that are reasonable and pragmatic. You need Animal Welfare and Antibiotic Policies to please customers, meet investor expectations and minimize risk of being targeted by animal advocacy groups.
As a boutique Animal Welfare Consultancy, we understand complex animal welfare issues including gestation crates, cage-free eggs, free-range meat and dairy, as well as, antibiotic and growth hormone issues. We understand industry positions and your competitors’ positions. We understand supply limitations and recommend a phased-in approach using our Responsible Sourcing Roadmap.
A recent study by the CDC and Pew Charitable Trust (PEW) indicates that 70 percent of antibiotics important for human medicine sold in the U.S. are used in livestock and poultry production, not for human medical use. The volume of medically important antibiotics sold for use in farmed animals continues to rise: it has gone up 23 percent in just the last five years.
Evidence is mounting showing that routine low-dosage use of antibiotics in farmed animals is negatively affecting human health. According to the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC) and other public health agencies, antibiotic resistance is a leading global public health threat. At least 2 million people in the U.S. contract antibiotic-resistant infections and at least 23,000 die as a result of the infections each year.
Antibiotic resistance happens when bacteria change to become stronger and resistant to the antibiotics used to treat the bacterial infection. The bacterial infection is no longer killed by the antibiotics and stronger antibiotics must be used. However, there are not always stronger antibiotics available, as resistance can happen faster than stronger antibiotics are being discovered and developed.